Ocular immune privilege: therapeutic opportunities from an experiment of nature
The DOI matches its Crossref record; 124 of the 125 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In the vitreous space, there are higher chances of exposure to systemic circulation,15 whereas the subretinal space does not expose AAV to systemic circulation, owing to the blood-retina barrier.9,33”
From Systemic and local immune responses to intraocular AAV vector administration in non-human primates (2022) · cites this paper as [9]
In the citing paper
“Idebenone (Raxone), a synthetic analogue of coenzyme Q10, has been used by practitioners in the European Union albeit with controversial efficacy, because results from a phase 3 study were not statistically different from placebo.11”
In the citing paper
“The eye was historically considered to be an immune privileged site, as a result of several features. These include the blood-retinal barrier formed by tight junctions between endothelial and retinal pigmented epithelium cells as well as in retinal vessels, the lack of anatomically defined lymphatic drainage and an intraocular anti-inflammatory and immunomodulatory micro-environment [43].”
From Characterization of anti-AAV2 neutralizing antibody levels in sheep prior to and following intravitreal AAV2.7m8 injection (2024) · cites this paper as [43]
In the citing paper
“Additionally, there are lower risks of immunogenicity when targeting AAV vectors towards relatively immune-privileged sites, such as the subretinal space and the cochlea [93,94].”
From Circumventing the packaging limit of AAV-mediated gene replacement therapy for neurological disorders (2022) · cites this paper as [93]
Citations
Cites
Fas Ligand-Induced Apoptosis as a Mechanism of Immune Privilege
Griffith, T. S., Brunner, T., Fletcher, S. M., Green, D. R., & Ferguson, T. A. (1995) · Science · doi:10.1126/science.270.5239.1189 · Cited by 2,005 · cited 1×
“CD95L, which is expressed constitutively by cells of the eye (and other immune-privileged tissues), is partially responsible for acceptance of orthotopic corneal allografts, and for making the cornea and retinal pigment epithelium immune-privileged tissue”
BackgroundMedawar, P. B. (1948) · PubMed · Cited by 1,109
Immunologically Privileged Sites
Barker, C. F., & Billingham, R. E. (1978) · Advances in Immunology · doi:10.1016/s0065-2776(08)60930-x · Cited by 815
PD-1:PD-L inhibitory pathway affects both CD4+ and CD8+ T cells and is overcome by IL-2
Carter, L. L., Fouser, L. A., Jussif, J., Fitz, L., Deng, B., Wood, C. R., Collins, M., Honjo, T., Freeman, G. J., & Carreno, B. M. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200203)32:3<634::aid-immu634>3.0.co;2-9 · Cited by 673
Immunobiology of Tissue Transplantation: A Return to the Passenger Leukocyte Concept
Laffery, K. J., Prowse, S. J., Simeonovic, C. J., & Warren, H. S. (1983) · Annual Review of Immunology · doi:10.1146/annurev.iy.01.040183.001043 · Cited by 509
Suda, T., Hashimoto, H., Tanaka, M., Ochi, T., & Nagata, S. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.12.2045 · Cited by 508 · cited 1×
“Attempts to achieve this goal with CD95L have already been made and the results are mixe”
ResultIdentification of transforming growth factor-beta as an immunosuppressive factor in aqueous humor.
Cousins, S. W., McCabe, M. M., Danielpour, D., & Streilein, J. W. (1991) · PubMed · Cited by 477
Self-citationKang, S.-M., Schneider, D. B., Lin, Z., Hanahan, D., Dichek, D. A., Stock, P. G., & Baekkeskov, S. (1997) · Nature Medicine · doi:10.1038/nm0797-738 · Cited by 450 · cited 1×
“First, conventional immune-recognition pathways can be interrupted by providing allografts with healthy corneal epithelium, or factors derived from this tissue that suppress lymphangiogenesis and attendant inflammatio”
BackgroundSo, K.-F., & Aguayo, A. J. (1985) · Brain Research · doi:10.1016/0006-8993(85)91047-9 · Cited by 390
CD95 ligand (FasL)-induced apoptosis is necessary for corneal allograft survival.
Stuart, P. M., Griffith, T. S., Usui, N., Pepose, J., Yu, X., & Ferguson, T. A. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119173 · Cited by 367 · cited 1×
“CD95L, which is expressed constitutively by cells of the eye (and other immune-privileged tissues), is partially responsible for acceptance of orthotopic corneal allografts, and for making the cornea and retinal pigment epithelium immune-privileged tissue”
Background
Research works printed but not linked: 5
- Haskova, Z., Arancibia-Carcamo, C. V., Christianson, G. J., Roopenian, D. C. & Ksander, B. R. in Uveitis in the Third Millenium (eds Dodds, E. M. & Couto, C. A.) 7–10 (Elsevier Science, Amsterdam, 2000).
- Sano, Y., Ksander, B. R. & Streilein, J. W. Fate of orthotopic corneal allografts in eyes that cannot support ACAID induction. Invest. Ophthalmol. Vis. Sci. 36, 2176–2185 (1995). This paper shows how immune privilege in the eye is disrupted by experimental manipulations of the cornea.
- Bora, H. S. et al. in Advances in Ocular Imunolology (eds Nussenblatt, R. B., Whitcup, S. M., Caspi, R. R. & Gery, I.) 83–86 (Amsterdam, Elsevier, 1994).
- Hori, J. & Streilein, J. W. Role of recipient epithelium in promoting survival of orthotopic corneal allografts in mice. Invest. Ophthalmol. Vis. Sci. 42, 720–726 (2001).
- Ishida, K., Panjwani, N., Cao, Z. & Streilein, J. W. Participation of pigment epithelium in ocular immune privilege. 3. Galectin-1 contributes to immunosuppressive properties of retinal pigment epithelium. Ocular Immun. Inflamm. (in the press).
Cited by
Items 301–400 of 806
The retinal pigment epithelium as a gateway for monocyte trafficking into the eye
Benhar, I., Reemst, K., Kalchenko, V., & Schwartz, M. (2016) · The EMBO Journal · doi:10.15252/embj.201694202 · Cited by 33
“The RPE plays an active role in sustaining the immune privileged status of the eye (Holtkamp et al , 2001; Streilein, 2003; Ambati et al , 2013; Stein-Streilein, 2013) by producing and secreting a variety of immunoregulatory factors (Holtkamp et al , 2001; Zamiri et al , 2007; Ma et al , 2009;…”
Sugita, S., Makabe, K., Iwasaki, Y., Fujii, S., & Takahashi, M. (2018) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.17-22703 · Cited by 33
Kinetics of corneal leukocytes by intravital multiphoton microscopy
Seyed‐Razavi, Y., Lopez, M. J., Mantopoulos, D., Zheng, L., Maßberg, S., Sendra, V. G., Harris, D. L., & Hamrah, P. (2018) · The FASEB Journal · doi:10.1096/fj.201800684rr · Cited by 33
“Antiinflammatory mediators, such as TGF-b and FasL (2–4), as well as the absence of major histocompatibility complex (MHC)-IIantigens (5), lackofblood(6),andlymphaticvessels (4), contribute to the maintenance of corneal immune privilege and thus, grant the corneaprotection from immunologic damage (7–10).”
BackgroundThe Role of Tissue Resident Memory CD4 T Cells in Herpes Simplex Viral and HIV Infection
O’Neil, T. R., Hu, K., Truong, N. R., Arshad, S., Shacklett, B. L., Cunningham, A. L., & Nasr, N. (2021) · Viruses · doi:10.3390/v13030359 · Cited by 37
Immune privilege of stem cells.
Ichiryu, N., & Fairchild, P. J. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-478-4_1 · Cited by 29
Yang, F., Chen, I.-L., Xiong, Z., Yan, Y., Wang, H., & Yang, X. (2006) · Clinical Immunology · doi:10.1016/j.clim.2006.06.007 · Cited by 31
Advancements in Understanding Immunogenicity of Biotherapeutics in the Intraocular Space
Wakshull, E., Quarmby, V. E., Mahler, H., Rivers, H. M., Jere, D., Ramos, M. F., Szczesny, P. J., Bechtold-Peters, K., Masli, S., & Gupta, S. (2017) · The AAPS Journal · doi:10.1208/s12248-017-0128-y · Cited by 29
Rong, X., Yang, J. P., Ji, Y., Zhu, X., Lü, Y., & Mo, X. (2018) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2018.12.032 · Cited by 31
Xu, J., Su, G., Huang, X., Chang, R., Chen, Z., Ye, Z., Cao, Q., Kijlstra, A., & Yang, P. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.587393 · Cited by 31
“Aqueous humor fills the anterior chamber of the eye and contributes to a normal intraocular homeostatic environment (12).”
BackgroundRegulatory T Cells and the Eye
Niederkorn, J. Y. (2007) · KARGER eBooks · doi:10.1159/000099263 · Cited by 31
Kontturi, L.-S., Collin, E. C., Murtomäki, L. S., Pandit, A. S., Yliperttula, M. L., & Urtti, A. O. (2014) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2014.10.005 · Cited by 32
“Notably, the eye can be considered as a potential site for this kind of cell therapy due to the immunosuppressive nature of the ocular microenvironment, or ocular immune privilege; the unique anatomical features of the blood-retinal barrier, the lack of direct lymphatic drainage, and the high concentrations of immunos…”
BackgroundMiyazaki, D., Haruki, T., Takeda, S., Sasaki, S.-I., Yakura, K., Terasaka, Y., Komatsu, N., Yamagami, S., Touge, H., Touge, C., et al. (2011) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.10-6911 · Cited by 30
Mature Dendritic Cell Suppression by IL-1 Receptor Antagonist on Retinal Pigment Epithelium Cells
Sugita, S., Kawazoe, Y., Imai, A., Usui, Y., Iwakura, Y., Isoda, K., Ito, M., & Mochizuki, M. (2013) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.12-11483 · Cited by 31
Marangoni, D., Wu, Z., Wiley, H. E., Zeiss, C. J., Vijayasarathy, C., Zeng, Y., Hiriyanna, S., Bush, R. A., Wei, L. L., Colosi, P., et al. (2014) · Human Gene Therapy Clinical Development · doi:10.1089/humc.2014.067 · Cited by 29
“Moreover, the existence of ocular immune privilege (Streilein, 2003) may reduce the likelihood of developing an immune response against the virus or its product, increasing thereby the effectiveness of the gene transfer.”
Mochizuki, M. (2009) · Acta Ophthalmologica · doi:10.1111/j.1755-3768.2009.01757.x · Cited by 34
“T cells from CTLA-4 KO mice are not suppressed by iris PE, indicating that interaction between CTLA-4 on T cells and B7-2 on iris PE is necessary for the T-cell suppression by iris PE (Sugita & Streilein 2003).”
BackgroundMethodInfluentialImai, A., Sugita, S., Kawazoe, Y., Horie, S., Yamada, Y., Keino, H., Maruyama, K., & Mochizuki, M. (2012) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.12-10182 · Cited by 28
Choi, J., Lee, J., Shin, M. E., Been, S., Lee, D. H., & Khang, G. (2020) · Polymers · doi:10.3390/polym12122941 · Cited by 28
“materials [7], and regulating immunities [8].”
Thompson, B. S., Davidson, E. A., Chen, Y., Orlicky, D. J., Thompson, D. C., & Vasiliou, V. (2021) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2022.109804 · Cited by 36
Effect of Humanin G (HNG) on inflammation in age-related macular degeneration (AMD)
Nashine, S., Cohen, P., Wan, J., & Kenney, M. C. (2022) · Aging · doi:10.18632/aging.204074 · Cited by 28
“However, acute insults contribute to retinal inflammation and subsequent retinal degeneration [3].”
BackgroundCompetency of iPSC-derived retinas in MHC-mismatched transplantation in non-human primates
Uyama, H., Tu, H., Sugita, S., Yamasaki, S., Kurimoto, Y., Matsuyama, T., Shiina, T., Watanabe, T., Takahashi, M., & Mandai, M. (2022) · Stem Cell Reports · doi:10.1016/j.stemcr.2022.09.014 · Cited by 30
“The eyes are unique immune-privileged sites (Streilein, 2003) that suppress immune responses and actively induce tolerance to foreign antigens (Keino et al.”
Retinal Laser Burn Disrupts Immune Privilege in the Eye
Qiao, H., Lucas, K. G., & Stein‐Streilein, J. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.080766 · Cited by 29
Dendritic cells in the cornea during Herpes simplex viral infection and inflammation
Kwon, M. S., Carnt, N. A., Truong, N. R., Pattamatta, U., White, A. J. R., Samarawickrama, C., & Cunningham, A. L. (2017) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2017.11.001 · Cited by 27
Expression of CRAMP via PGN-TLR-2 and of -defensin-3 via CpG-ODN-TLR-9 in corneal fibroblasts
Rodríguez–Martínez, S. (2006) · British Journal of Ophthalmology · doi:10.1136/bjo.2005.082289 · Cited by 28
Gaykema, L. H., van Nieuwland, R. Y., Lievers, E., Moerkerk, W. B. J., de Klerk, J. A., Dumas, S. J., Kers, J., Zaldumbide, A., van den Berg, C. W., & Rabelink, T. J. (2023) · Stem Cells Translational Medicine · doi:10.1093/stcltm/szad069 · Cited by 29
“11,12 14-16 Therefore, transplantation of tissue or cells in the kidney can potentially elicit a strong immune response.”
Hsu, S.-M., Mathew, R., Taylor, A. W., & Stein‐Streilein, J. (2013) · Clinical & Experimental Immunology · doi:10.1111/cei.12243 · Cited by 30
Eye‐Mediated Induction of Specific Immune Tolerance to Encephalitogenic Antigens
Farooq, S. M., & Ashour, H. M. (2013) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12087 · Cited by 29
The Role of the IL-20 Subfamily in Glaucoma
Wirtz, M. K., & Keller, K. E. (2016) · Mediators of Inflammation · doi:10.1155/2016/4083735 · Cited by 30
Recent advances in Toll‐like receptors and anterior uveitis
Chang, J. H., McCluskey, P., & Wakefield, D. (2012) · Clinical and Experimental Ophthalmology · doi:10.1111/j.1442-9071.2012.02797.x · Cited by 27
Melanoma vaccines: The problems of local immunosuppression
Polak, M. E., Borthwick, N., Jager, M. J., & Cree, I. A. (2009) · Human Immunology · doi:10.1016/j.humimm.2009.01.017 · Cited by 27
Anterior chamber–associated immune deviation and its impact on corneal allograft survival
Niederkorn, J. Y. (2006) · Current Opinion in Organ Transplantation · doi:10.1097/01.mot.0000236697.07092.ac · Cited by 28
Ocular Surface and Tear Film Changes in Older Women Working with Computers
Ribelles, A. B., Galbis-Estrada, C., Parras, M. A. P., Vivar-Llopis, B., Marco-Ramírez, C., & Díaz-Llopis, M. (2015) · BioMed Research International · doi:10.1155/2015/467039 · Cited by 31
The Immune Privileged Retina Mediates an Alternative Activation of J774A.1 Cells
Lau, C. H., & Taylor, A. W. (2009) · Ocular Immunology and Inflammation · doi:10.3109/09273940903118642 · Cited by 27
REVIEW Immunology of Intraocular Tumors
Niederkorn, J. Y., & Wang, S. (2005) · Ocular Immunology and Inflammation · doi:10.1080/09273940490518586 · Cited by 30
Ocular immunosuppressive microenvironment and novel drug delivery for control of uveitis
Teabagy, S., Wood, E., Bilsbury, E., Doherty, S., Janardhana, P., & Lee, D. J. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114869 · Cited by 29
Moderately Long-Term Safety and Efficacy of Repeat Penetrating Keratoplasty
Kitazawa, K., Wakimasu, K., Kayukawa, K., Yokota, I., Inatomi, T., Hieda, O., Sotozono, C., & Kinoshita, S. (2018) · Cornea · doi:10.1097/ico.0000000000001694 · Cited by 26
Emergent Temporal Signaling in Human Trabecular Meshwork Cells: Role of TRPV4-TRPM4 Interactions
Yarishkin, O. V., Phuong, T. T. T., Vázquez-Chona, F., Bertrand, J., Sherwood, J. M., Redmon, S. N., Rudzitis, C. N., Lakk, M., Baumann, J. M., Freichel, M., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.805076 · Cited by 26
Schlötzer-Schrehardt, U. M., André, S., Janko, C., Kaltner, H., Kopitz, J., Gabius, H., & i, M. H. (2012) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-012-2021-9 · Cited by 26
“Regarding galectin-dependent growth control, which appears to contribute to the ocular immune privilege [29, 63], the detection of Gal-9, a potent inducer of TH1 cell death [64], in RPE raises the possibility for its involvement.”
BackgroundAltenburger, A. E., Bachmann, B. O., Seitz, B., & Cursiefen, C. (2012) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-012-1988-6 · Cited by 26
Inhibition of B-Cell Activation by Retinal Pigment Epithelium
Sugita, S., Horie, S., Yamada, Y., & Mochizuki, M. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.09-5098 · Cited by 26
Safety Evaluation of Ocular Drugs
Ramos, M. F., Attar, M., Stern, M. E., Brassard, J. A., Kim, A. S., Matsumoto, S. S., & Vangyi, C. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803620-4.00029-3 · Cited by 29
McKenna, K. C., & Kapp, J. A. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.3.1599 · Cited by 26
The Blood-ocular Barriers and their Dysfunction: Anatomy, Physiology, Pathology
Braunger, B. M., Gießl, A., & Schlötzer-Schrehardt, U. M. (2023) · Klinische Monatsblätter für Augenheilkunde · doi:10.1055/a-2063-8957 · Cited by 33
“Finally, blood-ocular barriers are also a prerequisite for the immune privilege of the eye, which prevents nonspecific local tissue-damaging inflammatory processes in nonregenerative ocular tissues [3].”
Lighting the way: recent developments and applications in molecular optogenetics
Armbruster, A., Mohamed, A. M., Phan, H. T., & Weber, W. (2024) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2024.103126 · Cited by 29
Anti-Retinal Antibodies in Patients With Macular Telangiectasia Type 2
Zhu, L., Shen, W., Zhu, M., Coorey, N. J., Nguyen, A. P., Barthelmes, D., & Gillies, M. C. (2013) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.13-12050 · Cited by 28
Ildefonso, C. J., Kong, L., Leen, A. M., Chai, S. J., Petrochelli, V., Chintagumpala, M., Hurwitz, M. Y., Chévez‐Barrios, P., & Hurwitz, R. L. (2010) · Molecular Therapy · doi:10.1038/mt.2010.139 · Cited by 24
Fujii, S., Sugita, S., Futatsugi, Y., Ishida, M., Edo, A., Makabe, K., Kamao, H., Iwasaki, Y., Sakaguchi, H., Hirami, Y., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093077 · Cited by 25
“Although the subretinal space is an immune-privileged site [7], RPE allografts usually cause immune responses even in this space.”
BackgroundThe alchemy of immune privilege explored from a neuroimmunological perspective
Arck, P., Gilhar, A., Bienenstock, J., & Paus, R. (2008) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2008.06.003 · Cited by 30
Die Rolle des retinalen Pigmentepithels im Rahmen visueller Funktionen
Strauß, O. (2009) · Der Ophthalmologe · doi:10.1007/s00347-008-1869-x · Cited by 32
Suppression of IL-22–Producing T Helper 22 Cells by RPE Cells via PD-L1/PD-1 Interactions
Sugita, S., Kawazoe, Y., Imai, A., Usui, Y., Takahashi, M., & Mochizuki, M. (2013) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.13-12703 · Cited by 27
“Previous experimental evidence has demonstrated that some ocular parenchymal cells participate in the immune privilege of the eye.(1,2)”
BackgroundResultImmune Cells on the Corneal Endothelium of an Allogeneic Corneal Transplantation Rabbit Model
Koudouna, E., Okumura, N., Okazaki, Y., Nakano, S., Inoue, R., Fullwood, N. J., Hori, J., Kinoshita, S., & Koizumi, N. (2017) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.16-20019 · Cited by 25
Lie, S., Rochet, E., Segerdell, E., Ma, Y., Ashander, L. M., Shadforth, A. M. A., Blenkinsop, T. A., Michael, M., Appukuttan, B., Wilmot, B., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00708 · Cited by 25
“Ocular immune privilege describes the tissue, cellular and molecular mechanisms that limit inflammation inside the eye, to protect ocular immune functioning for preservation of vision (52).”
BackgroundTherapies Based on Principles of Ocular Immune Privilege
Zhang-Hoover, J., & Stein‐Streilein, J. (2007) · KARGER eBooks · doi:10.1159/000099281 · Cited by 25
Sonoda, K., Nakamura, T., Young, H. A., Hart, D. A., Carmeliet, P., & Stein‐Streilein, J. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.4.2215 · Cited by 25
“In brief, it is known that F4/80 APC carry the eye-inoculated Ag to the spleen during ACAID induction (4) and that the eye-derived APC secretes MIP-2 (27), which in turn selectively recruits iNKT cells (49) to the marginal zone (50) where they aggregate F4/80 APC (27), B cells (29, 51, 52), and conventional T cells (2…”
BackgroundFibrotic Changes in Rhegmatogenous Retinal Detachment
Harju, N., Kauppinen, A., & Loukovaara, S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26031025 · Cited by 29
Inflammation and Immune Pathways in Myopia: An Overview on Pathomechanisms and Treatment Prospects
Zhang, J., Kamoi, K., Zong, Y., Yang, M., Zou, Y., & Ohno‐Matsui, K. (2025) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-025-09094-7 · Cited by 32
“As an immune-privileged organ, the eye regulates immune responses through tolerance mechanisms, minimizing inflammatory damage to essential structures [12].”
Deletion of the Chemokine Receptor CCR1 Prolongs Corneal Allograft Survival
Hamrah, P., Yamagami, S., Liu, Y., Zhang, Q., Vora, S. S., Lu, B., Gerard, C. J., & Dana, M. R. (2007) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.05-1483 · Cited by 26
“IFN- can also synergize with IL-1 and TNF- to stimulate chemokine production, and as such, demonstration of the critical role of CCR1 in mediating corneal allograft rejection provides indirect confirmation for our previous work implicating IL-1 and TNF- in alloimmunity.(30,32,35,39,40) Leukocyte recruitment into the c…”
ResultMuhammad, F., Wang, D., McDonald, T., Walsh, M., Drenen, K., Montieth, A., Foster, C. S., & Lee, D. J. (2020) · Journal of Autoimmunity · doi:10.1016/j.jaut.2020.102441 · Cited by 24
“Uveitis is inflammation of the eye and can cause permanent damage to the light-gathering structures of the eye [10, 11].”
BackgroundRole of Bacterial and Host Factors in Infectious Endophthalmitis
Gregory, M. S., Callegan, M. C., & Gilmore, M. S. (2007) · KARGER eBooks · doi:10.1159/000099277 · Cited by 24
Wang, S., Coleman, E. J., Pop, L. M., Brooks, K. J., Vitetta, E. S., & Niederkorn, J. Y. (2005) · International Journal of Cancer · doi:10.1002/ijc.21289 · Cited by 25
“Multiple effector elements of both the innate and adaptive immune systems are profoundly suppressed in the AC of the eye.(27,38) Moreover, the aqueous humor that bathes AC tumors contains cytokines that can downregulate the expression of cell membrane epitopes on the surface of human uveal melanoma cells.”
BackgroundWest Nile Virus Infection Induces Interferon Signalling in Human Retinal Pigment Epithelial Cells
Cínatl, J., Michaelis, M., Fleckenstein, C., Bauer, G., Kabíčková, H., Scholz, M., Rabenau, H. F., & Doerr, H. W. (2006) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.05-1022 · Cited by 24
de Smet, M. D., Lynch, J. L., Dejneka, N. S., Keane, M., & Khan, I. J. (2018) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.17-22233 · Cited by 23
“While delivery of the cell product to the suprachoroidal space would be surgically easier, the subretinal space is an immune privilege site compared with all spaces beyond the RPE, which are not.(33) Cell survival would be decreased with delivery to the suprachoroidal space, and the possibility of retreatment if neede…”
BackgroundFarooq, S. M., Elkhatib, W. F., & Ashour, H. M. (2014) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2014.06.010 · Cited by 22
“Apart from conferring protection to the ocular compartment, antigen inoculation into the anterior chamber (AC) of the eye promotes a form of immune tolerance known as regulation of antigen-specific cell-mediated responses (Ashour and Niederkorn, 2006a,b; Streilein, 2003).”
BackgroundAntony, F., Pundkar, C. Y., Sandey, M., Jaiswal, A. K., Mishra, A., Kumar, A., Channappanavar, R., & Suryawanshi, A. S. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2000979 · Cited by 22
Immunopathogenesis of corneal graft rejection
Maharana, P. K., Mandal, S., Kaweri, L., Sahay, P., Lata, S., Asif, M. I., Nagpal, R., & Sharma, N. (2023) · Indian Journal of Ophthalmology · doi:10.4103/ijo.ijo_2866_22 · Cited by 27
“[1,2] Immune‐privileged sites are those where a transplanted graft survives for an extended period compared to a nonprivileged site.[3,4] Similarly, immune‐privileged tissues are the one that survive for an extended period when placed at conventional body sites compared to nonprivileged tissues that often get rejected.”
BackgroundThe Role of Nrf2/sMAF Signalling in Retina Ageing and Retinal Diseases
Zhang, J., Zhang, T., Zeng, S., Zhang, X., Zhou, F., Gillies, M. C., & Zhu, L. (2023) · Biomedicines · doi:10.3390/biomedicines11061512 · Cited by 29
“This is achieved by secreting immunomodulatory cytokines, neuropeptides, and growth factors into the intraocular fluid [59].”
Can the Hair Follicle Become a Model for Studying Selected Aspects of Human Ocular Immune Privilege?
Kinori, M., Kloepper, J. E., & Paus, R. (2011) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.10-7154 · Cited by 23
Role of NKT cells in anterior chamber-associated immune deviation
Niederkorn, J. Y. (2009) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.5.2.137 · Cited by 25
Molecular Circuits of Resolution in the Eye
Liclican, E. L., & Gronert, K. (2010) · The Scientific World JOURNAL · doi:10.1100/tsw.2010.99 · Cited by 22
“scarring in response to mild injury while maintaining unwavering host defense[3,4,5,6,9,12,13,14,15,16,17].”
BackgroundZhou, Y., Zhang, H., Zhang, G., He, Y., Zhang, P., Sun, Z., Gao, Y., & Tan, Y. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.8205 · Cited by 28
Immunoresolvent Resolvin D1 Maintains the Health of the Ocular Surface
Dartt, D. A., Hodges, R. R., & Serhan, C. N. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-21735-8_3 · Cited by 24
CD4+ T‐cell‐dependent tumour rejection in an immune‐privileged environment requires macrophages
Dace, D. S., Chen, P. W., & Niederkorn, J. Y. (2007) · Immunology · doi:10.1111/j.1365-2567.2007.02700.x · Cited by 28
Chattopadhyay, S., O’Rourke, J., & Cone, R. E. (2008) · International Immunology · doi:10.1093/intimm/dxn008 · Cited by 24
“The injection of antigen into the anterior chamber (AC) of an eye induces the systemic impairment of a cell-mediated immune response (1, 2 ). Antigens introduced into the AC are likely processed by F4/80+ antigen-presenting cells (APC)”
BackgroundComparing the Hem- and Lymphangiogenic Profile of Conjunctival and Uveal Melanoma Cell Lines
Refaian, N., Schlereth, S. L., Koch, K. R., Notara, M., Hos, D., Mescher, M., Iden, S., Bosch, J. J., Jager, M. J., Cursiefen, C., et al. (2015) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.15-16829 · Cited by 24
Potential applications of mesenchymal stem cells in ocular surface immune-mediated disorders
Surico, P. L., Barone, V., Singh, R. B., Coassin, M., Blanco, T., Dohlman, T. H., Basu, S., Chauhan, S. K., Dana, R., & Zazzo, A. D. (2024) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2024.07.008 · Cited by 26
Neutrophil Activities in Human Ocular Toxoplasmosis: An In Vitro Study With Human Cells
Ashander, L. M., Lie, S., Ma, Y., Rochet, E., Washington, J. M., Furtado, J. M., Appukuttan, B., & Smith, J. R. (2019) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.19-28306 · Cited by 22
“In general, the retinal pigment epithelium is considered immunoregulatory, being the major contributor to ocular immune privilege in the posterior segment of the eye.(33) The retinal pigment epithelium downregulates activation of CD4þ T helper cells and B cells, and promotes the differentiation of regulatory T cells.”
BackgroundYasuno, K., Hamamura-Yasuno, E., Nishimiya, D., Soma, M., Imaoka, M., Kai, K., & Mori, K. (2020) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2020.106694 · Cited by 22
Sugita, S., Futatsugi, Y., Ishida, M., Edo, A., & Takahashi, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186507 · Cited by 23
Sendra, V. G., Tau, J., Zapata, G., Vitar, R. M. L., Illian, E., Chiaradía, P., & Berra, A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.618597 · Cited by 22
“(A) and 11 (B) during acute HSV-1 keratitis exposed to clean (1) or polluted air (2).”
BackgroundEvaluation of the direct effects on retinal and choroidal microvascularity of systemic scleroderma
Kök, M., Ayan, A., Küçük, M. F., Erol, M. K., & Yaprak, L. (2021) · Microvascular Research · doi:10.1016/j.mvr.2021.104166 · Cited by 22
Do Oral Pathogens Inhabit the Eye and Play a Role in Ocular Diseases?
Arjunan, P., & Swaminathan, R. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11102938 · Cited by 27
Microbiome in Immune-Mediated Uveitis
Rodríguez-Fernández, C. A., Busto-Iglesias, M., de Domingo, B., Conde‐Pérez, K., Vallejo, J. A., Martinez, L. J. R., González‐Barcia, M., Llorenç, V., Mondelo‐García, C., Poza, M., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137020 · Cited by 25
“The inside of the eye contains multiple immune system cells and inflammatory mediators, but the immune privilege of the eyeball prevents intraocular inflammation through mechanisms of immune ignorance and immune tolerance [52].”
BackgroundInduction of T Regulatory Cells by Cytotoxic T-Lymphocyte Antigen-2α on Corneal Endothelial Cells
Sugita, S., Yamada, Y., Horie, S., Nakamura, O., Ishidoh, K., Yamamoto, Y., Yamagami, S., & Mochizuki, M. (2011) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.10-6322 · Cited by 22
Kobal, N., Marzidovšek, M., Schollmayer, P., Maličev, E., Hawlina, M., & Lužnik, Z. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252011121 · Cited by 29
“It is a form of immune tolerance to alloantigens placed in the anterior chamber of the eye that results in the downregulation of an antigen-specific delayed hypersensitivity response while promoting humoral immunity and the production of non-complement fixing antibodies [61].”
BackgroundNew Insights Into Immunological Therapy for Retinal Disorders
Takeda, A., Yanai, R., Murakami, Y., Arima, M., & Sonoda, K. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01431 · Cited by 23
“TGF-β is abundant in the vitreous humor to maintain an anti-inflammatory state in the eye (8).”
BackgroundInfluentialImmunopathogenic Background of Pars Planitis
Przeździecka-Dołyk, J., Węgrzyn, A., Turno‐Kręcicka, A., & Misiuk‐Hojło, M. (2015) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-015-0361-y · Cited by 22
“…non-classical MHC class Ib molecules and the enzyme indoleamine2,3-dioxygenase can be found in both the outer blood– retinal barrier and the blood-aqueous barrier epithelial milieu (Kaur et al. 2008; Kerr et al. 2008; Streilein 2003; Sugita 2009; Sugita et al. 2006a; Sugita and Streilein 2003).”
BackgroundPaunicka, K., Chen, P. W., & Niederkorn, J. Y. (2011) · Journal of Leukocyte Biology · doi:10.1189/jlb.0311173 · Cited by 25
“ACAID is the deviant systemic immune response evoked by introducing antigens into the AC of the eye and involves a unique cellular mechanism, in which noncomplement-fixing antibody responses are preserved, but destructive cellular reactions, such as DTH and CTL responses, are suppressed [7].”
BackgroundHe, J., Xiong, S., Zhou, W., Qiu, H., Rao, Y., Liu, Y., Shen, G., Zhao, P., Chen, G., & Li, J. (2024) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2024.134586 · Cited by 24
Li, Y., Tan, X., Ma, L., Li, H., Zhang, S.-H., Zeng, C.-M., Huang, L.-N., Xiong, J., & Fu, L. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-06081-8 · Cited by 23
Analysis of the Pathogenesis of Experimental Autoimmune Optic Neuritis
Kezuka, T., Usui, Y., & Goto, H. (2010) · Journal of Biomedicine and Biotechnology · doi:10.1155/2011/294046 · Cited by 21
“It is known that a specific immunoregulatory mechanism termed anterior chamber-associated immune deviation (ACAID) is present in the eye to maintain immune privilege in the intraocular environment [19].”
BackgroundNK cell depletion delays corneal allograft rejection in baby rats.
Schwartzkopff, J., Schlereth, S. L., Berger, M., Bredow, L., Birnbaum, F., Böhringer, D., & Reinhard, T. (2010) · PubMed Central · Cited by 20
Boneva, S., Groß, T. R., Schlecht, A., Schmitt, S. I., Sippl, C., Jägle, H., Volz, C., Neueder, A., Tamm, E. R., & Braunger, B. M. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.03.050 · Cited by 23
“However, the eye is an immune privileged organ with a high level of transforming growth factor (TGF)-β2, contributing to the quiescence of microglia and Müller cells [30,42,43,45,46].”
BackgroundSpecial regulatory T‐cell review: T‐cell dependent suppression revisited
Basten, A., & Groth, B. F. D. S. (2007) · Immunology · doi:10.1111/j.1365-2567.2007.02772.x · Cited by 20
From ocular immune privilege to primary autoimmune diseases of the eye
Nieto‐Aristizábal, I., Mera, J. J., Giraldo, J. D., Lopez-Arevalo, H., & Tobón, G. J. (2022) · Autoimmunity Reviews · doi:10.1016/j.autrev.2022.103122 · Cited by 24
Homeostasis and dyshomeostasis of the retina
Zhang, C.-J., & Jin, Z. (2023) · Current Medicine · doi:10.1007/s44194-023-00021-6 · Cited by 28
“This balance is disrupted when uncontrolled inflammation causes cellular injury and the organism is unable to create a stable and appropriate immune response to threats (Taylor and Kaplan 2010; Streilein 2003; Benhar et al.”
BackgroundBhowmick, S., Clark, R. B., Brocke, S., & Cone, R. E. (2011) · International Immunology · doi:10.1093/intimm/dxq461 · Cited by 22
LRG1 promotes corneal angiogenesis and lymphangiogenesis in a corneal alkali burn mouse model
Song, S. (2020) · International Journal of Ophthalmology · doi:10.18240/ijo.2020.03.01 · Cited by 19
Thrombospondin-1 and Pathogenesis of Age-Related Macular Degeneration
Housset, M., & Sennlaub, F. (2015) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2015.0023 · Cited by 22
“The eye and, in particular, the subretinal space have been shown to be immune privileged, as antigens introduced into these spaces do not yield an adoptive immune response.(58) Immune privilege is the result of local immunosuppressive environment that eliminates leukocytes and the specific suppression of antigen prese…”
Murakami, Y., Ikeda, Y., Yonemitsu, Y., Tanaka, S., Kondo, H., Okano, S., Kohno, R.-I., Miyazaki, M., Inoue, M., Hasegawa, M., et al. (2007) · The Journal of Gene Medicine · doi:10.1002/jgm.1142 · Cited by 19
“These vectorrelated immune responses might be further reduced in retinal gene transfer because the eye is known as an immune privileged site [14,15].”
BackgroundHan, Y., Chang, Q. A., Virág, T., West, N. C., George, D., Castro, M. G., & Bohn, M. C. (2010) · Gene Therapy · doi:10.1038/gt.2010.6 · Cited by 19
Glial grafting for demyelinating disease
Tepavčević, V., & Blakemore, W. F. (2005) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2005.1700 · Cited by 19
“…engraftment into the anterior chamber not only results in enhanced survival in comparison to the engraftment into the periphery, but also in a suppression of DTH responses to the engrafted antigens, a phenomenon named anterior chamber associated immune deviation (ACAID; reviewed by Streilein 2003).”
Metadata
- Authors
- Streilein, J. W.
- Affiliations
- Harvard University (US)
- Corresponding author
- Streilein, J. Wayne
- Venue
- Nature Reviews Immunology
- Published
- 2003-11
- Volume
- 3
- Issue
- 11
- Pages
- 879-889
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W2166550261
- Cited by
- 807
- References
- 125
- Citations by year
- 2026: 33 · 2025: 33 · 2024: 40 · 2023: 31 · 2022: 43 · 2021: 54 · 2020: 46 · 2019: 31 · 2018: 33 · 2017: 44 · 2016: 39 · 2015: 34 · 2014: 28 · 2013: 31 · 2012: 37
- FWCI
- 5.82
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Ophthalmology › Glaucoma and retinal disorders
- Keywords
- ocular immune privilege, eye, intraocular inflammation, vision loss, autoimmune eye disease, corneal transplantation, allograft acceptance, corneal immunology
- MeSH terms
- Animals, Autoimmune Diseases, Eye, Eye Diseases, Humans, Immunity, Inflammation, Transplantation, Homologous
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.